Hathal Haddad: Artificial Intelligence in Interventional Radiotherapy

Source Domain: oncodaily.com

Hathal Haddad, Head of Interventional Radiotherapy Unit at University Hospital Tübingen, highlights the advancements brought by Artificial Intelligence (AI) in Brachytherapy.
AI is transforming interventional radiotherapy, enhancing delivery of safer, faster, and more personalized treatments.
In Brachytherapy, particularly for prostate cancer, AI improves various clinical workflow steps like MRI target delineation and ultrasound-guided needle placement.
AI benefits include automatically contouring prostate and organs at risk, better target definition, improved needle and source reconstruction, real-time support during TRUS-guided implantations, reduced treatment planning time, and enhanced treatment consistency and quality.
The collaboration between human expertise and AI aims to create more precise, efficient, and patient-specific treatment plans, improving overall care.
The role of AI is to empower clinicians rather than replace them in the field of Brachytherapy.
Together, AI, skilled clinicians, and intelligent technologies work towards delivering better patient care, celebrating Brachytherapy Awareness Day on 17 July 2026.

You may have missed